In-stent stenosis: pathology and implications for the development of drug eluting stents
about
Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation'Miracle stents'--a future without restenosisRecent advances in drug eluting stentsSirolimus-eluting stents for treatment of in-stent restenosis: immediate and late resultsBerberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injuryAffinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.Impact of C-reactive protein on in-stent restenosis: a meta-analysis.Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine modelLymphaticosclerosis: a new way of thinking about lymphatic vessel obstructionEarly experiences and clinical implications of drug-eluting stents: part 1.In stent restenosis: bane of the stent era.Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetesIntimal Thickening after Placement of a Neuroform Stent. Its Incidence and Relation to Angiographic Follow-up Results of Aneurysm EmbolizationGlycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.Drug-eluting stents: from evidence to policy.A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.Cypher versus Taxus: the stent war.BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis.Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral ArteryThe correlation between early complications of percutaneous coronary intervention and high sensitive C-reactive proteinSystemic exposure of sirolimus after coronary stent implantation in patients with de novo coronary lesions: Supralimus-Core® pharmacokinetic study.Chronic Caffeine Administration Attenuates Vascular Injury-Induced Neointimal Hyperplasia in Rats.Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems.Research and innovation in the development of everolimus for oncology.Surface chemical and physical modification in stent technology for the treatment of coronary artery disease.Coronary stents: historical development, current status and future directions.Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases.Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury.Stent-mediated gene and drug delivery for cardiovascular disease and cancer: A brief insight.Paclitaxel-eluting nanofiber-covered self-expanding nonvascular stent for palliative chemotherapy of gastrointestinal cancer and its related stenosis.Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB.The relation of aortic stiffness and in-stent restenosis in patients undergoing percutaneous coronary stenting.Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway.Diagnosis and management challenges of in-stent restenosis in coronary arteries.A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.Critical Limb Ischemia: A Practical Up-To-Date Review.
P2860
Q21562470-0F4416D7-8E1D-4549-A5A5-1DEE55A56C20Q24645049-EAEE1FDE-3DF2-4B40-AF3E-D2AB5717A8DAQ27025538-3AEAC580-ACF4-4497-A8E8-D3F8A11F84D7Q28175715-16A06E9C-89A6-46D5-92E9-F98C428178CBQ28576577-EE33870D-0ACE-4779-9ED8-09DBB1186A90Q33314508-54E7C948-1175-43B9-9452-A1DDB1923734Q33693147-06AED156-B9BB-4F36-904F-796D8D28E361Q34089207-80898C95-2E5E-40AB-9E30-379EFE1C8566Q34432576-3F66B0E8-005A-4204-BCC8-FF8DDD9BB631Q35535453-DEA9572B-BCF6-4C0E-9100-08B80902808CQ35602368-31BFE242-CF49-4100-B757-A051986225E9Q35651217-B21D81B3-04E0-4FCE-8158-1784DE9B13CEQ35769824-AF951972-26B2-4B51-81DF-8FF2E8FAE59FQ35772244-ECD3ADE4-470C-4FB6-8B42-DAE6B3A6FD60Q35937571-81F17E8E-DE4A-471A-B12D-53639D108CBEQ36241566-6FB41C8B-21A9-4566-8655-436539332173Q36314909-5284132E-EB24-482B-B196-80B4AACD62E0Q36488244-28DB217C-EE5A-4F2B-863B-278499332B83Q36654328-3BDC7137-4E32-47F3-B12A-40BB95C5814CQ36728852-312DE15A-9F6D-4B1A-8F5F-1548FBFF4068Q37044202-567E722C-345B-4F16-B9FE-467C4E227CBFQ37102287-037842BC-E35E-4159-AE94-DEC5243B8CABQ37104135-0B0602C5-5E0B-48BA-BE0B-FC4A812D2088Q37387376-D8215703-636E-4278-9D6E-99E82F916029Q37406660-8F305D2D-0380-44F3-B82F-B4BE16DEB9B8Q37676695-DB95E487-533E-495E-8493-ACE5351904CEQ38014589-61A0C579-6D4F-4B3C-A806-9A66A3544C8AQ38040738-96AA3511-2535-4ABE-8DAF-599454377519Q38093501-702899F8-1A82-46D5-B420-EFC1EE2A6791Q38105361-2189F20C-02E8-43C1-9282-C91CF5EFF687Q38332355-035FFD3E-317E-40CC-954E-A61D15BA43BEQ38735846-CB6A9AF1-1449-4CCA-885A-6F7B4268196CQ38964790-A54E6122-1A35-4EC7-8518-63CF1972F077Q39052677-D42B09DD-6654-498A-AFF8-426931F374A4Q39438384-12C54AF1-022C-4451-9467-10A30B1F27A8Q39550187-1E23AF32-EE9B-422C-B61A-DE6A0BE3908BQ41608247-552EFE2B-0B5A-43E5-BB6C-6B7957389416Q42187564-9B32F962-9AE0-43C8-A195-58826104856BQ46701610-926A1FC4-DE11-4DDA-9FB7-37C77208D1CAQ47604696-921E1ED4-6DF2-4E4B-BF04-EA5DBDDA95DD
P2860
In-stent stenosis: pathology and implications for the development of drug eluting stents
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
In-stent stenosis: pathology and implications for the development of drug eluting stents
@ast
In-stent stenosis: pathology and implications for the development of drug eluting stents
@en
In-stent stenosis: pathology and implications for the development of drug eluting stents
@nl
type
label
In-stent stenosis: pathology and implications for the development of drug eluting stents
@ast
In-stent stenosis: pathology and implications for the development of drug eluting stents
@en
In-stent stenosis: pathology and implications for the development of drug eluting stents
@nl
prefLabel
In-stent stenosis: pathology and implications for the development of drug eluting stents
@ast
In-stent stenosis: pathology and implications for the development of drug eluting stents
@en
In-stent stenosis: pathology and implications for the development of drug eluting stents
@nl
P2860
P356
P1433
P1476
In-stent stenosis: pathology and implications for the development of drug eluting stents
@en
P2093
Martin R Bennett
P2860
P304
P356
10.1136/HEART.89.2.218
P407
P577
2003-02-01T00:00:00Z